0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.16%
Positive revenue growth while 0335.HK is negative. John Neff might see a notable competitive edge here.
20.10%
Positive gross profit growth while 0335.HK is negative. John Neff would see a clear operational edge over the competitor.
8.18%
Positive EBIT growth while 0335.HK is negative. John Neff might see a substantial edge in operational management.
8.18%
Positive operating income growth while 0335.HK is negative. John Neff might view this as a competitive edge in operations.
85.09%
Net income growth of 85.09% while 0335.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
84.38%
EPS growth of 84.38% while 0335.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
85.94%
Diluted EPS growth of 85.94% while 0335.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-6.85%
Share reduction while 0335.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
1.22%
Diluted share change of 1.22% while 0335.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
6.96%
Maintaining or increasing dividends while 0335.HK cut them. John Neff might see a strong edge in shareholder returns.
-10.98%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-15.47%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-35.10%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-46.64%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-44.46%
Negative 3Y CAGR while 0335.HK stands at 72.26%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-8146.73%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
36.76%
Positive OCF/share growth while 0335.HK is negative. John Neff might see a comparative advantage in operational cash viability.
-85.39%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-196.54%
Negative 10Y net income/share CAGR while 0335.HK is at 5529.84%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-102.54%
Negative 5Y net income/share CAGR while 0335.HK is 1301.89%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-108.70%
Negative 3Y CAGR while 0335.HK is 1320.19%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
88.86%
10Y equity/share CAGR at 50-75% of 0335.HK's 122.59%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
-3.72%
Negative 5Y equity/share growth while 0335.HK is at 14.68%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-12.03%
Negative 3Y equity/share growth while 0335.HK is at 2.91%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-18.72%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.37%
AR growth of 1.37% while 0335.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
20.84%
Inventory growth of 20.84% while 0335.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
2.58%
Asset growth 1.25-1.5x 0335.HK's 1.92%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
5.91%
BV/share growth above 1.5x 0335.HK's 1.54%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-3.03%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
146.15%
R&D growth of 146.15% while 0335.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
-18.01%
We cut SG&A while 0335.HK invests at 5.13%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.